Regulatory13 Aug 2026, 10:30 pm
Gaudium IVF: IPO Proceeds Monitoring Report for Q1 FY27
AI Summary
Gaudium IVF and Women Health Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by Infomerics Valuation and Rating Limited, confirms that there have been no deviations from the objects for which the Initial Public Offer (IPO) proceeds of ₹90.00 crore were earmarked. The monitoring agency reviewed bank statements, utilization certificates, board resolutions, and invoices to verify the utilization of funds. The company has also uploaded this report on its website.
Key Highlights
- Monitoring Agency Report for Q1 FY27 submitted.
- No deviation in IPO proceeds utilization reported.
- IPO proceeds amount to ₹90.00 crore.
- Infomerics Valuation and Rating Limited is the monitoring agency.
- Report confirms adherence to SEBI regulations.
Price Impact
More from GAUDIUMIVF